Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: tom jones who wrote (2544)	4/12/1999 7:43:00 PM
From: sim1	Read Replies (1) \| Respond to of 4676

I happen to have their Event Locator close at hand... All records where title contains "tomudex" PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (P) Biological Approaches I: Antisense Oligonucleotides and Receptor Antagonists Apr 11 1999 8:00AM "Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of Tomudex, 5-FU, 5-FUdR, and methotrexate in HeLa cells." Apr 11 1999 8:00AM "Effects of antisense oligodeoxynucleotides (ODNs) targeting against thymidylate synthase (TS) on the growth and Tomudex sensitivity of human tumor cell lines in vivo." CLINICAL RESEARCH (P) Gastrointestinal Cancer I: Colorectal and Hepatobiliary Cancers Apr 12 1999 1:00PM "Activity of the combination tomudex + irinotecan in human colon carcinoma cells resistant to fluorouracil." Phase I Clinical Trials Apr 11 1999 8:00AM "Influence of tomudex on the pharmacokinetics of 5-FU and its metabolism: A phase I trial."